Company Profile

Data Sciences International (AKA: Transoma Medical)
Profile last edited on: 1/31/2019      CAGE: 0X8U1      UEI:

Business Identifier: Implantable wireless diagnostic and monitoring devices for chronic cardiovascular disease patients
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

119 14th Street Nw Suite 100
St. Paul, MN 55112
   (651) 481-7400
Location: Multiple
Congr. District: 04
County: Ramsey

Public Profile

Data Sciences International (DSI), formerly dba Transoma Sciences, is a medical technology company working in the implantable wireless diagnostic and monitoring products space. In January 2018, DSI was acquired by Harvard Bioscience - itself an SBIR firm. In the physiologic monitoring technology arena, DSI had offered the Sleuth ECG Monitoring System, an implantable wireless system to capture electrocardiogram data for diagnosing cardiac arrhythmias, as well as to monitor the electrical activity of the heart and transmit data from the patient's home to monitoring centers. The firm pioneered use of wireless implantable telemetric devices for monitoring and collecting physiological data from conscious, freely moving laboratory animals. The company is also in the process of adapting its core telemetry technology for the human-use medical device market.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2002 2 NIH $850,000
Project Title: Ultraminiature Telemetry Implant For Medical Monitoring
2001 1 NIH $126,432
Project Title: Implantable Pressure/Electrogram Sensor for CHF
2001 2 NIH $1,373,011
Project Title: Implantable Pressure, Flow and ECG Telemetry
2001 1 NIH $134,467
Project Title: Implantable Blood Flow Device
1998 2 NIH $821,508
Project Title: Telemetry Implant For Mouse Blood Pressure Monitoring

Key People / Management

  Elbert (Bert) Harman -- President; Chief Executive Officer

  Brian P Brockway -- Former President

  Charles Coggin -- Executive Vice President; Chief Financial Officer

  Peter Fritsche -- Vice President, Quality

  Kristen Knox -- Vice President, Global Sales & Marketing

  Perry Mills -- VP of Research & Developm

  Perry A Mills

Company News

There are no news available.